Pilot Study on Next-Generation Sequencing Analysis of Vaginal Microbiota in Clinically Infertile Patients Treated with Probiotics

• Published in: Journal of clinical medicine 2024-06, Vol.13 (12), p.3420
• Main Authors: Lin, Li-Te, Li, Chia-Jung, Wu, Chia-Chun, Pan, Li-Fei, Tsui, Kuan-Hao
• Format: Article
• Language: English
• Subjects: Care and treatment; Females; Fertility; Genetic testing; Health aspects; In vitro fertilization; Infertility; Infertility, Female; Menstruation; Microbiota; Microbiota (Symbiotic organisms); Middle aged women; Patient outcomes; Physiological aspects; Pregnancy; Probiotics; Reproductive health; Structure; Taxonomy; Vagina; Women; Womens health
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm13123420

: In this investigation, we aimed to understand the influence of oral probiotic supplementation on the vaginal microbiota of women preparing for assisted reproductive technology (ART) procedures. Given the importance of a healthy microbiome for reproductive success, this study sought to explore how probiotics might alter the bacterial composition in the vaginal environment. : We recruited a cohort of 30 women, averaging 37 years of age (ranging from 31 to 43 years), who were scheduled to undergo ART. Using 16S ribosomal RNA (rRNA) sequencing, we meticulously analyzed the vaginal microbiota composition before and after the administration of oral probiotic supplements. : Our analysis identified 17 distinct microorganisms, including 8 species of Lactobacillus. Following probiotic supplementation, we observed subtle yet notable changes in the vaginal microbiota of some participants. Specifically, there was a decrease in Gardnerella abundance by approximately 20%, and increases in Lactobacillus and Bifidobacterium by 10% and 15%, respectively. Additionally, we noted a significant reduction in the Firmicutes/Bacteroidetes (F/B) ratio in the probiotic group, indicating potential shifts in the overall bacterial composition. : These preliminary findings suggest that oral probiotic supplementation can induce significant changes in the vaginal microbiota of middle-aged women undergoing ART, potentially improving their overall bacterial profile. Future studies should consider a larger sample size and a narrower age range to validate these results. Investigating factors related to female hormone production could also provide deeper insights. Understanding the effects of probiotics on the vaginal microbiota in patients with ovarian aging may lead to personalized interventions and better reproductive outcomes.